Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
British Journal of Cancer|May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databasesThomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Frontiers in Oncology|June 7, 2021
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated AssaysGeoffroy Poulet, Fanny Garlan, Sonia Garrigou, et al.
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Journal of the National Cancer Institute|February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO StudyDavid Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Liver Cancer|September 26, 2022
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic HepatocholangiocarcinomaElia Gigante, Christian Hobeika, Brigitte Le Bail, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 4, 2018
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort studyPierre Rompteaux, Johan Gagnière, Jean-Marc Gornet, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2021
Prognostic factors of colorectal cancer patients with brain metastasesPauline Roussille, Marie Auvray, Damien Vansteene, et al.
British Journal of Cancer|May 14, 2024
Genomic profiling of small bowel adenocarcinoma: a pooled analysis from 3 databasesThomas Aparicio, Julie Henriques, Magali Svrcek, et al.
Frontiers in Oncology|June 7, 2021
Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated AssaysGeoffroy Poulet, Fanny Garlan, Sonia Garrigou, et al.
The Lancet. Oncology|April 26, 2025
TFOX versus FOLFOX in first-line treatment of patients with advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma (PRODIGE 51- FFCD-GASTFOX): an open-label, multicentre, randomised, phase 3 trialAziz Zaanan, Olivier Bouché, Christelle de la Fouchardière, et al.
International Journal of Molecular Sciences|April 23, 2022
Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal CancersCamille Evrard, Stéphane Messina, David Sefrioui, et al.
Journal of the National Cancer Institute|February 4, 2016
Efficacy of Adjuvant Chemotherapy in Colon Cancer With Microsatellite Instability: A Large Multicenter AGEO StudyDavid Tougeron, Guillaume Mouillet, Isabelle Trouilloud, et al.
International Journal of Cancer|January 24, 2020
Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter studyDavid Tougeron, Benjamin Sueur, Aziz Zaanan, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 7, 2023
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma-a retrospective, international, multicentric AGEO studyElisabeth S Bergen, Lorenzo Pilla, Edouard Auclin, et al.
Liver Cancer|September 26, 2022
Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic HepatocholangiocarcinomaElia Gigante, Christian Hobeika, Brigitte Le Bail, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 4, 2018
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort studyPierre Rompteaux, Johan Gagnière, Jean-Marc Gornet, et al.
Pageof 13